People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Wegovy is an injectable medication that contains semaglutide, the same active ingredient as Ozempic, but in a slightly higher dose. However, unlike Ozempic, Wegovy is FDA approved for weight ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Novo Nordisk’s Ozempic (semaglutide ... study evaluating a higher dose of semaglutide in adults with obesity. Among patients who adhered to treatment in the phase 3b STEP UP trial, those receiving the ...

WASHINGTON — (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been ... “Some folks have to skip a dose in their prescription so they can make a prescription last ...